Ensari Güneli, DVM, PhD
This laboratory will offer proof-of-principle pharmacology studies (pharmacodynamic and pharmacokinetic) in relevant animal models of human diseases. These studies will be performed under GLP guidelines. To allow the regulatory requirements to be met, animal models for pharmacological studies will be customized to the specific requirements and, if need be, developed further. IBG will have state-of-the-art animal facilities equipped to house immune-compromised animals, genetically modified models, and other rodents. All experimental procedures involving animals will be conducted according to Turkish Law and International Rules.